Effects of mallotus furetianus extract on CYP3A activities in rats

Mallotus furetianus is traditionally used as folk medicine on Hainan Island, China. Given the significance of the pharmacokinetic interaction between herbs and drugs, we investigated the effects of Mallotus furetianus ethanol extract (MFE) on CYP3A activity in rats. The major bioactive constituents of MFE, gallic acid (GA) and epigallocatechin gallate (EGCG), were analyzed by Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) for MFE standardization. Rats were orally administered 320 mg/10mL/kg MFE or water (control) once a day for 7 days. Two hours after the last MFE treatment, the rats were euthanized, and the livers and small intestines were excised. The activity of CYP3A was measured in hepatic and intestinal microsomes, and the expression in hepatic and intestinal tissues was assessed by qRT-PCR and western blot. In the pharmacokinetics experiment, rats were administered MFE as described above. Two hours after the final dose of MFE, a 15 mg/kg midazolam solution was orally administered. Blood samples were collected before and after midazolam administration. Midazolam plasma concentration and 1-hydroxymidazolam formation in microsomes were measured by LC-MS/MS methods.CYP3A activity in hepatic microsomes exhibited a significant decrease in MFE treatment group, while no change was observed in intestinal microsomes. MFE treatment significantly increased CYP3A1 activity, as well as mRNA and protein expression in the small intestine but reduced these parameters in the liver. However, CYP3A2 remained unaffected by MFE treatment. Pharmacokinetics study showed that administration of MFE for 7 days significantly reduced the Cmax of midazolam from 919 ± 70 ng / mL to 708 ± 91 ng /mL. Conversely, t1/2 was increased from 0.45 ± 0.08 h in the control group to 0.69 ± 0.15 h in the MFE group.Collectively, our study indicated that MFE could modulate CYP3A1 activity and expression of CYP3A1, subsequently changing the metabolism of midazolam in rats.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-05-27
DOI
https://doi.org/10.1038/s41598-025-02193-7
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of mallotus furetianus extract on CYP3A activities in rats

Hyo In Kim, Jin Bong Park, Peiqiong Li, Wei Huang et al.
1 links
Scientific Reports
Pharmacogenetics and Drug Metabolism
article

Effects of mallotus furetianus extract on CYP3A activities in rats

Hyo In Kim, Jin Bong Park, Peiqiong Li, Wei Huang, Shuang Li, Feng Cao
article en

Abstract

Mallotus furetianus is traditionally used as folk medicine on Hainan Island, China. Given the significance of the pharmacokinetic interaction between herbs and drugs, we investigated the effects of Mallotus furetianus ethanol extract (MFE) on CYP3A activity in rats. The major bioactive constituents of MFE, gallic acid (GA) and epigallocatechin gallate (EGCG), were analyzed by Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) for MFE standardization. Rats were orally administered 320 mg/10mL/kg MFE or water (control) once a day for 7 days. Two hours after the last MFE treatment, the rats were euthanized, and the livers and small intestines were excised. The activity of CYP3A was measured in hepatic and intestinal microsomes, and the expression in hepatic and intestinal tissues was assessed by qRT-PCR and western blot. In the pharmacokinetics experiment, rats were administered MFE as described above. Two hours after the final dose of MFE, a 15 mg/kg midazolam solution was orally administered. Blood samples were collected before and after midazolam administration. Midazolam plasma concentration and 1-hydroxymidazolam formation in microsomes were measured by LC-MS/MS methods.CYP3A activity in hepatic microsomes exhibited a significant decrease in MFE treatment group, while no change was observed in intestinal microsomes. MFE treatment significantly increased CYP3A1 activity, as well as mRNA and protein expression in the small intestine but reduced these parameters in the liver. However, CYP3A2 remained unaffected by MFE treatment. Pharmacokinetics study showed that administration of MFE for 7 days significantly reduced the Cmax of midazolam from 919 ± 70 ng / mL to 708 ± 91 ng /mL. Conversely, t1/2 was increased from 0.45 ± 0.08 h in the control group to 0.69 ± 0.15 h in the MFE group.Collectively, our study indicated that MFE could modulate CYP3A1 activity and expression of CYP3A1, subsequently changing the metabolism of midazolam in rats.

Scientific ReportsVol. 15(1)
Beth Israel Deaconess Medical Center (US), Hainan University (CN), Hainan Medical University (CN)
Natural Science Foundation of Hainan Province
Zero hunger
Openalex Percentile: Top 85%
Pharmacogenetics and Drug Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.